Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q2

Ironwood Pharmaceuticals (IRWD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.17. This compares to earnings of$0.31 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -100%. A quarter ago, it was expected that this drugmaker would post earnings of $0.18 per share when it actually produced a loss of$0.02, delivering a surprise of -111.11%. Over the last four quarters, the company has ...